More on: vitamin K antagonists and cancer.
G
G
Agnelli
M R
MR
Taliani
P
P
Prandoni
D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000453:epidemiology / Q000209:etiology* / Q000517:prevention & control; D013997:Time Factors; D054556:Venous Thromboembolism / Q000150:complications / Q000188:drug therapy; D014812:Vitamin K / Q000037:antagonists & inhibitors*; D014859:Warfarin / Q000008:administration & dosage* / Q000009:adverse effects
D000925:Anticoagulants; D014812:Vitamin K; D014859:Warfarin